Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease.

Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G, Ciulla D, Tabbaa D, Ingram J, Schauer DB, Ward DV, Korzenik JR, Xavier RJ, Bousvaros A, Alm EJ.

PLoS One. 2012;7(6):e39242. doi: 10.1371/journal.pone.0039242. Epub 2012 Jun 29.

2.

Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.

Yang Z, Clark N, Park KT.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):253-62.e2. doi: 10.1016/j.cgh.2013.06.028. Epub 2013 Jul 21.

3.

Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.

Shaw KA, Bertha M, Hofmekler T, Chopra P, Vatanen T, Srivatsa A, Prince J, Kumar A, Sauer C, Zwick ME, Satten GA, Kostic AD, Mulle JG, Xavier RJ, Kugathasan S.

Genome Med. 2016 Jul 13;8(1):75. doi: 10.1186/s13073-016-0331-y.

4.

The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.

Henderson P, Casey A, Lawrence SJ, Kennedy NA, Kingstone K, Rogers P, Gillett PM, Wilson DC.

Am J Gastroenterol. 2012 Jun;107(6):941-9. doi: 10.1038/ajg.2012.33. Epub 2012 Feb 28.

PMID:
22370604
5.

Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA.

J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74.

PMID:
17460505
6.

Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.

Knoll RL, Forslund K, Kultima JR, Meyer CU, Kullmer U, Sunagawa S, Bork P, Gehring S.

Am J Physiol Gastrointest Liver Physiol. 2017 Apr 1;312(4):G327-G339. doi: 10.1152/ajpgi.00293.2016. Epub 2016 Dec 30.

7.

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.

Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.

Gut. 2007 Dec;56(12):1706-13. Epub 2007 Aug 3.

8.

Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.

Voiosu T, Benguş A, Dinu R, Voiosu AM, Bălănescu P, Băicuş C, Diculescu M, Voiosu R, Mateescu B.

J Gastrointestin Liver Dis. 2014 Sep;23(3):273-8. doi: 10.15403/jgld.2014.1121.233.thv.

9.

Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease.

Wang AY, Popov J, Pai N.

World J Gastroenterol. 2016 Dec 21;22(47):10304-10315. doi: 10.3748/wjg.v22.i47.10304. Review.

10.

Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.

Kolho KL, Korpela K, Jaakkola T, Pichai MV, Zoetendal EG, Salonen A, de Vos WM.

Am J Gastroenterol. 2015 Jun;110(6):921-30. doi: 10.1038/ajg.2015.149. Epub 2015 May 19.

PMID:
25986361
11.

Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease.

Docktor MJ, Paster BJ, Abramowicz S, Ingram J, Wang YE, Correll M, Jiang H, Cotton SL, Kokaras AS, Bousvaros A.

Inflamm Bowel Dis. 2012 May;18(5):935-42. doi: 10.1002/ibd.21874. Epub 2011 Oct 10.

12.

Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.

Aomatsu T, Imaeda H, Fujimoto T, Takahashi K, Yoden A, Tamai H, Fujiyama Y, Andoh A.

Digestion. 2012;86(2):129-35. doi: 10.1159/000339777. Epub 2012 Jul 27.

PMID:
22846404
13.

Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.

Chehoud C, Albenberg LG, Judge C, Hoffmann C, Grunberg S, Bittinger K, Baldassano RN, Lewis JD, Bushman FD, Wu GD.

Inflamm Bowel Dis. 2015 Aug;21(8):1948-56. doi: 10.1097/MIB.0000000000000454.

14.

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.

Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.

Dig Liver Dis. 2014 Nov;46(11):974-9. doi: 10.1016/j.dld.2014.07.013. Epub 2014 Aug 2.

PMID:
25096964
15.

Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.

Oyaert M, Trouvé C, Baert F, De Smet D, Langlois M, Vanpoucke H.

Clin Chem Lab Med. 2014 Mar;52(3):391-7. doi: 10.1515/cclm-2013-0699.

PMID:
24114912
16.

Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.

Imhann F, Vich Vila A, Bonder MJ, Fu J, Gevers D, Visschedijk MC, Spekhorst LM, Alberts R, Franke L, van Dullemen HM, Ter Steege RWF, Huttenhower C, Dijkstra G, Xavier RJ, Festen EAM, Wijmenga C, Zhernakova A, Weersma RK.

Gut. 2018 Jan;67(1):108-119. doi: 10.1136/gutjnl-2016-312135. Epub 2016 Oct 8.

17.

Accuracy of four fecal assays in the diagnosis of colitis.

Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F.

Dis Colon Rectum. 2007 Oct;50(10):1697-706.

PMID:
17762964
18.

Fecal pyruvate kinase is not suitable for discrimination between inflammatory bowel disease exacerbation and acute gastroenteritis.

Czub E, Nowak JK, Moczko J, Mankowski P, Lisowska A, Banaszkiewicz A, Banasiewicz T, Walkowiak J.

Dev Period Med. 2015 Apr-Jun;19(2):167-73.

19.

Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.

van Gaal N, Lakenman R, Covington J, Savage R, de Groot E, Bomers M, Benninga M, Mulder C, de Boer N, de Meij T.

J Breath Res. 2017 Nov 29;12(1):016006. doi: 10.1088/1752-7163/aa6f1d.

PMID:
28439048
20.

Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.

Caviglia GP, Pantaleoni S, Touscoz GA, Adriani A, Rosso C, Smedile A, Pellicano R, Astegiano M, Bresso F.

Scand J Gastroenterol. 2014 Dec;49(12):1419-24. doi: 10.3109/00365521.2014.934913. Epub 2014 Nov 5.

Supplemental Content

Support Center